Skip to content
Bora Pharmaceuticals
-
Bora Group expands US biologics footprint with US$127.5M MacroGenics CDMO acquisition
The acquisition includes MacroGenics’ biologics drug substance manufacturing facility in Rockville, Maryland, as well as a warehousing center in Frederick, Maryland, located about 30 miles away.
-
GSK renews USD250M manufacturing deal with Bora Pharmaceuticals through 2030
Under the renewed agreement, Bora will provide end-to-end manufacturing services for more than 20 commercial GSK product lines.